Goes, Fernando S. https://orcid.org/0000-0001-6262-8264
Collado-Torres, Leonardo
Zandi, Peter P. https://orcid.org/0000-0001-8423-2623
Huuki-Myers, Louise https://orcid.org/0000-0001-5148-3602
Tao, Ran
Jaffe, Andrew E. https://orcid.org/0000-0001-6886-1454
Pertea, Geo https://orcid.org/0000-0002-3210-7182
Shin, Joo Heon https://orcid.org/0000-0002-5563-8605
Weinberger, Daniel R. https://orcid.org/0000-0003-2409-2969
Kleinman, Joel E. https://orcid.org/0000-0002-4210-6052
Hyde, Thomas M. https://orcid.org/0000-0002-8746-3037
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH111721)
Article History
Received: 28 January 2025
Accepted: 10 April 2025
First Online: 28 April 2025
Competing interests
: A.E.J. is currently an employee and shareholder of Neumora Therapeutics, which is unrelated to the contents of this manuscript. The other authors declare no conflicts of interest.